You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR SUMATRIPTAN SUCCINATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SUMATRIPTAN SUCCINATE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00329355 ↗	Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)	Completed	GlaxoSmithKline	Phase 3	2006-05-01	This study was designed to determine efficacy of TREXIMET (sumatriptan/naproxen sodium), formerly known as TREXIMA compared to placebo for the treatment of a menstrual migraine.
NCT00329459 ↗	Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea	Completed	GlaxoSmithKline	Phase 3	2006-05-01	This study was designed to determine efficacy of TREXIMA compared to placebo for the treatment of a menstrual migraine.
NCT00356603 ↗	Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan	Completed	GlaxoSmithKline	Phase 3	2006-06-20	This study will be conducted to collect cases treated by self-injection of sumatriptan 3mg kit product for the treatment of migraine or cluster headache attacks in clinical settings, to demonstrate the efficacy, and to examine patient acceptability (simplicity and usefulness) and rate of successful self-injection.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SUMATRIPTAN SUCCINATE

Condition Name

Chart
Table

Condition Name for SUMATRIPTAN SUCCINATE
Intervention	Trials
Migraine Disorders	11
Healthy	8
Migraine	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SUMATRIPTAN SUCCINATE
Intervention	Trials
Migraine Disorders	17
Headache	2
Premenstrual Syndrome	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SUMATRIPTAN SUCCINATE

Trials by Country

Map
Table

Trials by Country for SUMATRIPTAN SUCCINATE
Location	Trials
United States	184
India	3
Canada	1
Japan	1
China	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SUMATRIPTAN SUCCINATE
Location	Trials
Florida	10
Missouri	10
California	9
Tennessee	9
North Carolina	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SUMATRIPTAN SUCCINATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SUMATRIPTAN SUCCINATE
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	11
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SUMATRIPTAN SUCCINATE
Clinical Trial Phase	Trials
Completed	24
Recruiting	1
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SUMATRIPTAN SUCCINATE

Sponsor Name

Chart
Table

Sponsor Name for SUMATRIPTAN SUCCINATE
Sponsor	Trials
GlaxoSmithKline	10
NuPathe Inc.	4
Mylan Pharmaceuticals	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SUMATRIPTAN SUCCINATE
Sponsor	Trials
Industry	25
Other	12
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.